
Eli Lilly's latest trial results and new licensing agreement show promise in treating psoriasis, obesity, and kidney disease.
You can purchase shares of CSL LTD SP/ADR by CSL Ltd. (OTCQX:CSLLY) through any online brokerage.
There are no as such competitors for CSL LTD SP/ADR by CSL Ltd..
There is no analysis for CSL LTD SP/ADR by CSL Ltd. to provide a consensus price target.
The stock price for CSL LTD SP/ADR by CSL Ltd. (OTCQX: CSLLY) is $34.5705 last updated October 27, 2026 at 1:34 PM EDT.
There are no upcoming dividends for CSL LTD SP/ADR by CSL Ltd..
CSL LTD SP/ADR by CSL Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for CSL LTD SP/ADR by CSL Ltd..
CSL LTD SP/ADR by CSL Ltd. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQX.
CSL is one of the largest global biotech companies and has three main segments. CSL Behring uses either plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL...